Literature DB >> 25544249

Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level.

Yoel Shufaro1, Onit Sapir2, Galia Oron2, Avi Ben Haroush2, Roni Garor2, Haim Pinkas2, Tzippy Shochat2, Benjamin Fisch2.   

Abstract

OBJECTIVE: To investigate the impact of late follicular phase progesterone (P) elevation in relation to ovarian response on cycle outcome.
DESIGN: Cohort study. The progesterone-to-follicle index (PFI) was calculated by dividing the blood P by the number of follicles ≥14 mm. The clinical pregnancy rate was calculated against the range of PFI values and blood P levels.
SETTING: In vitro fertilization unit. PATIENT(S): A heterogenous population undergoing IVF with pituitary suppression and gonadotropin stimulation resulting in 3-15 follicles ≥14 mm and blood P≤10 nmol/L on hCG day and resulting in fresh embryo transfer. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Association of blood P and PFI with clinical pregnancy rate. RESULT(S): Data were retrieved for 8,649 IVF cycles in normal responders. The (reverse) odd ratios for pregnancy were 1.112 (95% confidence interval [CI], 1.077-1.165) for blood P and 4.104 (95% CI, 3.188-5.284) for the PFI. Elevated P levels were associated with a lower pregnancy rate only when they reached the >93rd percentile. The PFI was inversely and linearly related to the pregnancy rate for the whole range of values. CONCLUSION(S): A late increase in P level is detrimental if it is a consequence of increased P production per follicle (high PFI) but not if it is a consequence of additional follicular recruitment. The PFI enables clinicians to differentiate these conditions.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IVF; follicle; progesterone; progesterone-to-follicle index

Mesh:

Substances:

Year:  2014        PMID: 25544249     DOI: 10.1016/j.fertnstert.2014.11.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Revisiting the progesterone to oocyte ratio.

Authors:  Micah J Hill; Mae Wu Healy; Kevin S Richter; Eric Widra; Eric D Levens; Alan H DeCherney; George Patounakis; Brian W Whitcomb
Journal:  Fertil Steril       Date:  2017-01-06       Impact factor: 7.329

Review 2.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

3.  Ratio of progesterone-to-number of follicles as a prognostic tool for in vitro fertilization cycles.

Authors:  Matheus Roque; Marcello Valle; Marcos Sampaio; Selmo Geber; Miguel Angel Checa
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

4.  Progesterone levels on the human chorionic gonadotropin trigger day affect the pregnancy rates for embryos transferred at different stages of development in both general and selected IVF/ICSI populations.

Authors:  P Merviel; S Bouée; A S Jacamon; J J Chabaud; M T Le Martelot; S Roche; C Rince; H Drapier; A Perrin; D Beauvillard
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-06       Impact factor: 3.007

5.  Elevated serum progesterone does not impact euploidy rates in PGT-A patients.

Authors:  Maria Luisa Pardiñas; Mar Nohales; Elena Labarta; José María De Los Santos; Amparo Mercader; José Remohí; Ernesto Bosch; Maria José De Los Santos
Journal:  J Assist Reprod Genet       Date:  2021-05-18       Impact factor: 3.357

6.  Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles.

Authors:  Ju Hee Park; Byung Chul Jee; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2015-06-30

Review 7.  Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology.

Authors:  Baiju Ahemmed; Vani Sundarapandian; Rohit Gutgutia; Sathya Balasubramanyam; Richa Jagtap; Reeta Biliangady; Priti Gupta; Sachin Jadhav; Ruma Satwik; Pavitra Raj Dewda; Priti Thakor; Sandro C Esteves
Journal:  Int J Reprod Med       Date:  2017-01-26

8.  Association of progesterone production with serum anti-Müllerian hormone levels in assisted reproductive technology cycles with corifollitropin alfa.

Authors:  Tsung-Hsien Lee; Shu-Ling Tzeng; Chun-I Lee; Hsiu-Hui Chen; Chun-Chia Huang; Shee-Uan Chen; Maw-Sheng Lee
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

9.  Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization.

Authors:  Hwajeong Lee; Hyun Joung Choi; Kwang Moon Yang; Min Jung Kim; Sun Hwa Cha; Hyun Jeong Yi
Journal:  Obstet Gynecol Sci       Date:  2017-12-19

Review 10.  Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles.

Authors:  Sandro C Esteves; Gautam Khastgir; Jatin Shah; Kshitiz Murdia; Shweta Mittal Gupta; Durga G Rao; Soumyaroop Dash; Kundan Ingale; Milind Patil; Kunji Moideen; Priti Thakor; Pavitra Dewda
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.